Side Effects > Palivizumab

Palivizumab Side Effects

Brand Names: Synagis

Please note - some side effects for Palivizumab may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

Side Effects of Palivizumab - for the Consumer

Palivizumab

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Palivizumab:

Cough; diarrhea; mild fever; minor pain, redness, swelling, or warmth at the injection site; runny or stuffy nose; upset stomach; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur when using Palivizumab:

Severe allergic reactions (rash; hives; itching; difficulty breathing or swallowing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness; muscle weakness or limpness); blue lips or skin (including under the fingernails); ear pain or discharge; fever; irregular heartbeat; stomach pain; unusual bruising or bleeding; wheezing.

Top

Side Effects by Body System

General

Most of the reported adverse reactions documented are derived from studies of the drug in the pediatric patient. These have included anaphylaxis, acute hypersensitivity reactions, upper respiratory infection, otitis media, fever, rhinitis, hernia, and SGOT elevation.

Cardiovascular

Cardiovascular side effects have included arrhythmia during studies of congenital heart disease patients.

Gastrointestinal

Gastrointestinal side effects have included mild nausea, moderate vomiting, and diarrhea.

Hematologic

Hematologic side effects have included mild eosinophilia and thrombocytopenia. Severe thrombocytopenia (platelet count less than 50,000/microliter) has been reported during postmarketing experience.

Hypersensitivity

Hypersensitivity side effects have included severe acute hypersensitivity reactions and anaphylaxis (including dyspnea, cyanosis, respiratory failure, urticaria, pruritus, angioedema, hypotonia, and unresponsiveness) during postmarketing experience.

Local

Local side effects have included injection site reactions during postmarketing experience.

Other

Other side effects have included cyanosis during studies of congenital heart disease patients.

Top

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.